LeMaitre Vascular Announces Details for Its December 3rd Investor and Analyst Day
This event is open to all investors and analysts. It will feature presentations by senior management who will discuss the Company's positioning, corporate strategy and growth opportunities followed by question and answer sessions. During the event, the Company plans to reiterate its financial outlook for the fourth quarter and full year 2015 that it previously announced on
To RSVP for in-person attendance, please email
A webcast will be available live on the Investor Relations page of the Company's website at www.lemaitre.com/investor. A recorded replay of the webcast will be available on the same Investor Relations page shortly after the conclusion of the event.
LeMaitre and the
Statements made in this release may be forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such "forward-looking statements" regarding the Company's business that are not historical facts may involve risks and uncertainties. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ from the results predicted. These risks and uncertainties include, but are not limited to, the risk that the Company may not realize the anticipated benefits of its strategic activities; the risk that assumptions about the market for the Company’s products and the productivity of the Company’s direct sales force and distributors may not be correct; risks related to the integration of acquisition targets; risks related to product demand and market acceptance of the Company’s products and pricing; the risk that the XenoSure product is not as accretive and does not achieve the gross margins currently anticipated by the Company; the risk that the Company is not successful in transitioning to a direct-selling model in new territories; adverse or fluctuating conditions in the general domestic and global economic markets and other risks and uncertainties included under the heading "Risk Factors" in its most recent Annual Report on Form 10-K, as updated by its subsequent filings with the
LeMaitre Vascular, Inc. Kimberly Cieslak+1-781-425-1653 firstname.lastname@example.org http://www.lemaitre.com